Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 47,112 | 29,242 | 18,862 | 29,259 |
| Marketable Securities | N/A | 4,225 | 6,309 | 5,705 | 8,225 |
| Receivables | N/A | 12,973 | 12,560 | 10,260 | 10,086 |
| Inventories | N/A | 6,138 | 5,773 | 5,791 | 3,721 |
| TOTAL | $N/A | $73,423 | $55,612 | $42,284 | $52,695 |
| Non-Current Assets | |||||
| PPE Net | N/A | 11,831 | 13,867 | 14,853 | 14,580 |
| Investments And Advances | 0 | 7,463 | 39,780 | 41,671 | 40,320 |
| Intangibles | 0 | 1,063 | 10,049 | 10,952 | 11,900 |
| Other Non-Current Assets | 0 | 2,454 | 8,598 | 9,097 | 10,069 |
| TOTAL | $N/A | $22,811 | $72,294 | $76,573 | $76,869 |
| Total Assets | $N/A | $96,234 | $127,906 | $118,857 | $129,564 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,001 | N/A |
| Accounts payable and accrued liabilities | 0 | 3,289 | 3,098 | 4,598 | 7,171 |
| Accrued Expenses | N/A | 11,816 | 23,651 | 7,576 | 6,701 |
| Other current liabilities | N/A | N/A | 3,000 | N/A | N/A |
| TOTAL | $N/A | $17,005 | $29,749 | $13,175 | $13,872 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -178 | 34,459 | 33,780 | 35,894 | 37,686 |
| TOTAL | $N/A | $34,655 | $36,446 | $38,739 | $40,703 |
| Total Liabilities | $N/A | $51,660 | $66,195 | $51,914 | $54,575 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 13,458 | 13,606 | 13,606 | 13,606 |
| Common Shares | N/A | 1 | 1,373 | 1,373 | 1,374 |
| Retained earnings | N/A | -637,160 | -624,856 | -620,571 | -613,626 |
| Other shareholders' equity | 0 | -1,033 | -2,019 | -228 | 2,061 |
| TOTAL | $N/A | $44,574 | $61,711 | $66,943 | $74,989 |
| Total Liabilities And Equity | $0 | $96,234 | $127,906 | $118,857 | $129,564 |